Understanding Pulmonary Sarcoidosis Staging and Lung Function Tests
Last updated:
Pulmonary sarcoidosis is monitored using the Scadding Staging System (based on imaging) and pulmonary function tests (PFTs). Your Scadding stage helps predict if the disease will resolve on its own, while PFTs like FVC and DLCO track lung health to determine if treatment is needed.
Key Takeaways
- • The Scadding Staging System uses chest X-rays to classify pulmonary sarcoidosis from Stage 0 (normal) to Stage IV (permanent scarring).
- • Your Scadding stage helps doctors predict the likelihood of spontaneous remission, which is highest in the earliest stages.
- • High-Resolution CT (HRCT) scans are more sensitive than standard X-rays and are excellent for identifying permanent lung scarring like honeycombing.
- • Pulmonary function tests (PFTs) track lung volume (FVC) and oxygen transfer (DLCO) to monitor if the disease is progressing.
- • A drop of 10% or more in your FVC between clinic visits is a standard indicator that the disease may be worsening and might require treatment.
Pulmonary sarcoidosis is most commonly tracked using two main tools: imaging (X-rays and CT scans) and breathing tests (Pulmonary Function Tests). These results help your doctor determine your “stage” and whether your lungs are functioning well enough to continue monitoring without medication, or if it is time to consider treatment [1][2].
The Scadding Staging System
Doctors use the Scadding Staging System to categorize how sarcoidosis looks on a chest X-ray. This staging is primarily a way to predict the likelihood that the disease will go away on its own (spontaneous remission) [3].
| Stage | What It Shows on X-Ray | Chance of Remission |
|---|---|---|
| Stage 0 | Normal chest X-ray [4] | Very High |
| Stage I | Enlarged lymph nodes in the chest (hilar lymphadenopathy) [5] | 60% – 90% [3] |
| Stage II | Enlarged lymph nodes plus spots in the lung tissue (infiltrates) [3] | 40% – 70% [3] |
| Stage III | Spots in the lung tissue without enlarged lymph nodes [3] | 10% – 20% [3] |
| Stage IV | Permanent scarring or fibrosis in the lungs [6] | Near 0% [3] |
X-Ray vs. High-Resolution CT (HRCT)
While the Scadding stages are based on X-rays, many doctors prefer High-Resolution Computed Tomography (HRCT) for a more detailed view [4][7].
- Superior Accuracy: HRCT is much more sensitive than a standard X-ray. It can find tiny nodules and lymph node changes that an X-ray might miss [8][9].
- Identifying Fibrosis: HRCT is the best tool for identifying “Stage IV” features like traction bronchiectasis (stretched airways) or honeycombing (clusters of cystic spaces), which are signs of permanent scarring [6].
Demystifying Pulmonary Function Tests (PFTs)
Breathing tests measure how well your lungs are working. Two specific numbers are most important in sarcoidosis [10]:
- Forced Vital Capacity (FVC): This is the total amount of air you can exhale after taking the deepest breath possible. It measures lung “volume.” A drop in FVC of 10% or more between visits is the standard clinical threshold for significant disease progression [10]. A smaller drop of 5% may also be concerning, but primarily if it represents a sustained downward trend over multiple visits or is accompanied by worsening symptoms [11].
- DLCO (Diffusing Capacity): This measures how easily oxygen moves from your lungs into your bloodstream [10]. It is often the most sensitive marker; a DLCO below 60% predicted may indicate significant lung involvement even if your FVC is normal [10].
Your Completeness Checklist
When reviewing your medical records or imaging reports, look for these specific terms to help prepare for your next appointment:
- Stage Confirmation: Does the report explicitly state a Scadding Stage (0-IV)?
- Activity Markers: Does the report mention ground-glass opacities? These often suggest active inflammation that may respond to treatment [6].
- Scarring Markers: Does it mention fibrosis, honeycombing, or volume loss? These suggest permanent changes [6].
- Lymph Nodes: Are there mentions of hilar or mediastinal lymphadenopathy?
- PFT Percentages: Check your “Percent Predicted” (% Pred) for FVC and DLCO. Numbers above 80% are generally considered normal, while numbers below 50% may indicate severe impairment [12].
- 6-Minute Walk Test: If performed, did your oxygen levels stay above 90% while walking? [13]
Frequently Asked Questions
What is the Scadding Staging System for sarcoidosis?
Why might my doctor order an HRCT scan instead of a standard chest X-ray?
What do FVC and DLCO mean on my lung function test?
What does Stage IV sarcoidosis mean?
Can pulmonary sarcoidosis go away on its own?
Questions for Your Doctor
- • Based on my chest X-ray, what is my Scadding stage, and how does that stage typically correlate with the chance of spontaneous remission?
- • Does my HRCT show any signs of 'Stage IV' findings like traction bronchiectasis or honeycombing that could indicate permanent scarring (fibrosis)?
- • My DLCO and FVC percentages are [insert numbers]—how do these compare to the thresholds where you typically recommend starting treatment?
- • Since HRCT is more sensitive than X-rays, would a follow-up CT scan be more helpful than a repeat X-ray for monitoring my lung changes over time?
- • Are my current symptoms—like my level of cough or breathlessness—consistent with the amount of inflammation or scarring you see on my scans?
Questions for You
- • Looking at your imaging report, does it mention words like 'hilar lymphadenopathy,' 'micronodules,' or 'fibrosis'?
- • Have you noticed your shortness of breath getting worse during specific activities, like climbing stairs or walking long distances?
- • If you've had multiple breathing tests, have your 'FVC' or 'DLCO' percentages shown a downward trend between visits?
- • How do you feel about a 'watchful waiting' approach versus starting medication, assuming your lung function is currently stable?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study.
El Jammal T, Jamilloux Y, Gerfaud-Valentin M, et al.
Diagnostics (Basel, Switzerland) 2021; (11(7)) doi:10.3390/diagnostics11071240.
PMID: 34359324 - 2
Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis.
Gerke AK
Journal of clinical medicine 2024; (13(3)) doi:10.3390/jcm13030738.
PMID: 38337432 - 3
Pulmonary sarcoidosis: A comprehensive review: Past to present.
Belperio JA, Fishbein MC, Abtin F, et al.
Journal of autoimmunity 2024; (149()):103107 doi:10.1016/j.jaut.2023.103107.
PMID: 37865579 - 4
The role of chest X-ray in the early diagnosis and staging of sarcoidosis: Is it really should be done?
Koc AS, Oncel G, Ince O, et al.
Reumatologia clinica 2023; (19(10)):560-564 doi:10.1016/j.reumae.2023.10.003.
PMID: 38056981 - 5
Prognosis of sarcoidosis and factors affecting prognosis.
Bilgin B, Bilgin MK, Erol S, et al.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2023; (40(4)):e2023054 doi:10.36141/svdld.v40i4.13244.
PMID: 38126508 - 6
High-Resolution CT Scan Fibrotic Patterns in Stage IV Pulmonary Sarcoidosis: Impact on Pulmonary Function and Survival.
Obi ON, Alqalyoobi S, Maddipati V, et al.
Chest 2024; (165(4)):892-907 doi:10.1016/j.chest.2023.10.021.
PMID: 37879560 - 7
Novelties in Imaging of Thoracic Sarcoidosis.
Calandriello L, D'Abronzo R, Pasciuto G, et al.
Journal of clinical medicine 2021; (10(11)) doi:10.3390/jcm10112222.
PMID: 34063811 - 8
Chest high-resolution computed tomography can make higher accurate stages for thoracic sarcoidosis than X-ray.
Zhang Y, Du SS, Zhao MM, et al.
BMC pulmonary medicine 2022; (22(1)):146 doi:10.1186/s12890-022-01942-y.
PMID: 35429968 - 9
Thoracic Sarcoidosis: Imaging with High Resolution Computed Tomography.
Dhagat PK, Singh S, Jain M, et al.
Journal of clinical and diagnostic research : JCDR 2017; (11(2)):TC15-TC18 doi:10.7860/JCDR/2017/24165.9459.
PMID: 28384959 - 10
Pulmonary Function in Pulmonary Sarcoidosis.
Yao Q, Ji Q, Zhou Y
Journal of clinical medicine 2023; (12(21)) doi:10.3390/jcm12216701.
PMID: 37959167 - 11
One-year lung function decline in sarcoidosis.
Tanizawa K, Handa T, Nagai S, et al.
Respiratory investigation 2024; (62(1)):9-12 doi:10.1016/j.resinv.2023.09.005.
PMID: 37925884 - 12
Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.
Ungprasert P, Crowson CS, Carmona EM, Matteson EL
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2018; (35(2)):123-128 doi:10.36141/svdld.v35i2.6356.
PMID: 32476891 - 13
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
Gupta R, Baughman RP, Nathan SD, et al.
Respiratory medicine 2022; (196()):106801 doi:10.1016/j.rmed.2022.106801.
PMID: 35316723
This page explains pulmonary sarcoidosis staging and lung function tests for educational purposes. Always consult your pulmonologist to interpret your specific imaging and PFT results.
Stay up to date
Get notified when new research about Sarcoidosis is published.
No spam. Unsubscribe anytime.